To coincide with the return of our Bee Allergy Aware campaign, Anaphylaxis UK has launched a brand-new fundraising initiative to help raise awareness of bee and wasp allergy across UK schools.
Read moreWe are moving our AllergyWise® courses to our new learning platform on the Anaphylaxis UK website. The new platform provides a smoother training experience and features our updated and improved AllergyWise® for Schools course.
Read moreWe have launched our new Allergy Aware School 2022-2023 award to recognise and reward schools across the UK committed to raising allergy awareness with staff and pupils.
Read moreWe were very saddened to learn of the death of 13-year-old Karanbir Cheema. Our Chief Executive has been in contact with the family and attended the pre-inquest this week. Karanbir was known to have severe eczema, bronchial asthma for which
Read moreEarlier this week on Wednesday 14th March 2018 our Chief Executive Lynne Regent was delighted to attend a House of Commons debate on ‘Allergy Awareness in Schools’. Westminster Hall debates in the Grand Committee Room allow time for individual MPs
Read moreThe ‘Beast from the East’ and ‘Storm Emma’ mean many weather warnings have been in place this week as snow and icy conditions grip the nation. Our helpline and information team have received some queries about how to store adrenaline
Read moreYou may have seen in the news that Ide Primary School in Exeter has received criticism for introducing a ‘nut-free environment’ policy and the subsequent coverage in the Daily Mail Online. The Anaphylaxis Campaign provided a full statement to the
Read more07/07/2017 New legislation was passed in Westminster this week to allow schools in the UK to keep spare adrenaline auto injectors (AAIs) for emergency use. AAI devices deliver a potentially life-saving dose of adrenaline in the event of a severe
Read moreNursing in schools: how school nurses support pupils with long-term health conditions looked at school nurses’ confidence in managing five prevalent long-term health conditions: asthma, epilepsy, diabetes, anaphylaxis and eczema. The research included a national survey, completed by one in
Read more